Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism. - He Q; Tao F; Wen X; Zhu L; Ye X (Clinical & experimental metastasis, 2026)